Patents Issued in October 2, 2007
-
Patent number: 7276605Abstract: The present invention concerns a method for producing recombinant trypsin from porcine pancreas in Pichia pastoris which is soluble and secreted into the culture medium, whereby expression at pH 3.0-4.0 substantially prevents activation of trypsinogen to ?-trypsin and autolysis of ?-trypsin by ?-trypsin into ?-trypsin and from there into inactive peptides.Type: GrantFiled: February 1, 2002Date of Patent: October 2, 2007Assignee: Roche Diagnostics Operations, Inc.Inventors: Rainer Muller, Stephan Glaser, Frank Geipel, Johann-Peter Thalhofer, Bernhard Rexer, Claus Schneider, Michael Ratka, Stephanie Ronning, Hellmut Eckstein, Claudia Giessel
-
Patent number: 7276606Abstract: The present invention relates to compounds of the general formula (IV) and (II) and salts and physiologically functional derivatives thereof, wherein X is C—R8 or N; and Z is independently one of the following groups:Type: GrantFiled: May 2, 2005Date of Patent: October 2, 2007Assignee: 4SC AGInventors: Stefano Pegoraro, Martin Lang, Juliane Feurle, Juergen Kraus
-
Patent number: 7276607Abstract: Substituted carbocyclic sulphonamide derivatives of formula (I), in which n is 0 or 1 and the other variables are as defined in the claims, are selective 5-HT7 receptor antagonists and are thereby effective in the treatment of a variety of neurological conditions, including depression and sleep disorders.Type: GrantFiled: November 29, 2002Date of Patent: October 2, 2007Assignee: Merck Sharp & Dohme LimitedInventors: Neil Roy Curtis, Peter Alan Hunt, Janusz Jozef Kulagowski
-
Patent number: 7276608Abstract: The invention provides for compounds of formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of eating disorders, metabolic disorders, obesity, cognitive disorders, neurological disorders, pain disorders, inflammation disorders, in the promotion of smoking cessation and for the treatment of other psychiatric disorders Also provided are pharmaceutical compositions containing such compounds and pharmaceutical combinations of the compounds of the invention with other therapeutic agents.Type: GrantFiled: July 12, 2004Date of Patent: October 2, 2007Assignee: Bristol-Myers Squibb CompanyInventors: Philip M. Sher, Chongqing Sun, Richard B. Sulsky, Gang Wu, William R. Ewing
-
Patent number: 7276609Abstract: The present invention concerns a process for preparing 4-(hydroxy)-[1,4?]bipiperidinyl-1?-carboxylic acid tert-butyl ester, comprising hydrogenating a mixture of 4-hydroxypiperidine and 1-tert-butoxycarbonyl-4-piperidone in a suitable solvent, in the presence of a suitable catalyst and at a suitable pressure.Type: GrantFiled: October 2, 2002Date of Patent: October 2, 2007Assignee: AstraZeneca ABInventors: Philip O'Keefe, Mark Purdie
-
Patent number: 7276610Abstract: The invention provides novel GlyT2 inhibiting compounds useful in modulating, treating, or preventing: anxiolytic disorders; a condition requiring treatment of injured mammalian nerve tissue; a condition amenable to treatment through administration of a neurotrophic factor; a neurological disorder; or obesity; an obesity-related disorder.Type: GrantFiled: August 17, 2004Date of Patent: October 2, 2007Assignee: Janssen Pharaceutica, NVInventors: Charles Q. Huang, Timothy W. Lovenberg, Alejandro Santillán, Jr., Liu Y. Tang, Ronald L. Wolin
-
Patent number: 7276611Abstract: There is provided a process for the preparation of bicyclicheteroaryl carboxaldehydes having the structural Formula I where X and Y are defined in the specification The bicyclic heteroaryl carboxaldehydes are useful as intermediates in the preparation of ?-lactamase inhibitors.Type: GrantFiled: May 12, 2004Date of Patent: October 2, 2007Assignee: Wyeth Holdings CorporationInventors: Michael William Winkley, Anita Wai-Yin Chan, Ivo L. Jirkovsky, Kenneth Alfred Martin Kremer, Joseph Zeldis, Antonia Aristotelevna Nikitenko, Henry Lee Strong, Tarek Mansour, Gulnaz Khafizova, Aranapakam M. Venkatesan
-
Patent number: 7276612Abstract: The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.Type: GrantFiled: April 6, 2004Date of Patent: October 2, 2007Assignee: Pharmacyclics, Inc.Inventors: Eric J. Verner, Martin Sendzik, Chitra Baskaran, Joseph J. Buggy, James Robinson
-
Patent number: 7276613Abstract: Novel retro-anandamides are presented which have high affinities for the cannabinoid CB1 and/or CB2 receptor sites. Further, most of the analogs exhibit greater metabolic stability than arachidonylethanolamide. The improved receptor affinity and selectivity and/or greater metabolic stability make these analogs therapeutically useful as medications in individuals and animals for treatment of pain, glaucoma, epilepsy, nausea associated with chemotherapy, as well as suppression of the immune system, enhancement of appetite and in treatment of certain mental disorders.Type: GrantFiled: October 18, 2000Date of Patent: October 2, 2007Assignee: University of ConnecticutInventors: Alexandros Makriyannis, Qian Liu, Andreas Goutopoulos
-
Patent number: 7276614Abstract: Disclosed is a compound of the formula wherein R1 and R1? each, independently of the other, is an alkyl group having at least one ethylenic unsaturation, an arylalkyl group having at least one ethylenic unsaturation, or an alkylaryl group having at least one ethylene unsaturation, R2, R2?, and R3 each, independently of the others, are alkylene groups, arylene groups, arylalkylene groups, or alkylarylene groups, and n is an integer representing the number of repeat amide units and is at least 1.Type: GrantFiled: November 30, 2005Date of Patent: October 2, 2007Assignee: Xerox CorporationInventors: Eniko Toma, Peter G. Odell, Adela Goredema, Jennifer L. Belelie
-
Patent number: 7276615Abstract: A process for preparing a metal oxide having groups of the general formula I —O1+n—SiR12?n—CH2—Y??(I) which involves reacting a solid having OH groups on the surface with silanes of the general formula II RO1+n—SiR12?n—CH2—Y??(II) where Y is a functional group —NRx2, —OC(O)C(R)?CH2, -halo, or —NCO. The reaction takes place rapidly and at reasonable temperatures and avoids production of significant quantities of decomposition products or byproducts, providing a metal oxide with a high proportion of Y functional groups.Type: GrantFiled: April 29, 2004Date of Patent: October 2, 2007Assignee: Wacker Chemie AGInventors: Torsten Gottschalk-Gaudig, Herbert Barthel, Juergen Pfeiffer
-
Patent number: 7276616Abstract: The use of a phosphorus containing Ligand as a Ligand for a metathesis catalyst in a catalysed metathesis reaction wherein the phosphorus containing Ligand is a heterocyclic organic compound with a ligating phosphorus atom as an atom in the heterocyclic ring structure of the heterocyclic organic compound. The invention also relates to a metathesis catalyst such a phosphorus containing Ligand and to a metathesis reaction using the catalyst.Type: GrantFiled: July 4, 2003Date of Patent: October 2, 2007Assignee: Sasol Technology (UK) LimitedInventors: Catherine Lynn Dwyer, Ann Elizabeth Catherine McConnell, Grant Stephen Forman
-
Patent number: 7276617Abstract: An object of the invention is to provide an organic EL element which uses an organometallic complex emitting light by phosphorescence and which represents excellent luminous efficiency, etc; or the like. The organic EL element of the invention includes the organometallic complex, where the organometallic complex includes a metal atom, and a tridentate ligand, where the tridentate ligand binds to the metal atom tridentately via two nitrogen atoms and a carbon atom, and the carbon atom is located between the two nitrogen atoms, and where the tridentate ligand has two azomethine bonds (—C?N—), and each nitrogen atom in the azomethine bonds coordinates to the metal atom. Preferably, in one aspect, the organometallic complex includes a monodentate ligand which binds to the metal atom monodentately, and in another aspect, the metal atom is Pt.Type: GrantFiled: March 16, 2006Date of Patent: October 2, 2007Assignee: Fujifilm CorporationInventors: Wataru Sotoyama, Tasuku Satoh, Hiroyuki Sato, Azuma Matsuura, Norio Sawatari
-
Patent number: 7276618Abstract: The invention relates to a composition comprising a compound of formula (I): Rf—B—Ro—Z and a compound of formula (II): and/or their reaction product.Type: GrantFiled: June 21, 2002Date of Patent: October 2, 2007Assignee: E. I. du Pont de Nemours and CompanyInventors: Didier Juhue, Marie-Jose Lina, Anne-Claire Gayon, Jean-Marc Corpart
-
Patent number: 7276619Abstract: A process for the purification of a silicone oil or fluid using neat supercritical carbon dioxide or a supercritical carbon dioxide mixture extraction to produce vitreoretinal silicone tamponades. The subject process is an economical, highly effective, reproducible, contaminant-free method by which unreacted relatively low molecular weight cyclic siloxanes and oligomers are removed from relatively high molecular weight silicone oil or fluid.Type: GrantFiled: March 16, 2004Date of Patent: October 2, 2007Assignee: Bausch & Lomb IncorporatedInventors: Jay F. Kunzler, Joseph C. Salamone, Dharmendra Jani, Erik M. Indra
-
Patent number: 7276620Abstract: A method of phosphorodiamidite production comprising the steps of reacting a phosphorus trihalide with a dialkyl amine in a polar solvent to form an intermediate compound. This intermediate compound is then subsequently reacted with an hydroxylalkyl compound and a dialkyl amine in the presence of a non-polar cosolvent. Following filtration to remove the solid by-product the two solvents form separate layers. This is advantageous as the upper, non-polar solvent, layer contains the high-purity phosphorodiamidite product.Type: GrantFiled: December 18, 2003Date of Patent: October 2, 2007Assignee: Rhodia Consumer Specialties LimitedInventors: Christopher John Harris, Sheena Lesley Jackson, David James Wilson
-
Patent number: 7276621Abstract: Disclosed is a process for the preparation of di-(2-ethylhexyl) terephthalate by the esterification of terephthalic acid with 2-ethylhexanol at elevated temperature and pressure while the water of reaction is removed from the reaction mixture.Type: GrantFiled: August 12, 2005Date of Patent: October 2, 2007Assignee: Eastman Chemical CompanyInventors: Steven Leroy Cook, Christopher Fletcher Tomlin, Phillip Wayne Turner
-
Patent number: 7276622Abstract: It is provided that a method for producing an oxygen-containing compound, characterized in that an olefin compound having a carbon-carbon double bond which is bonded to a methyl or methylene group is reacted with an organic hydroperoxide in the presence of an ionic liquid and a selenium compound.Type: GrantFiled: March 23, 2004Date of Patent: October 2, 2007Assignee: Sumitomo Chemical Company, LimitedInventor: Koji Hagiya
-
Patent number: 7276623Abstract: Ester compounds having formula (1) wherein R1 is fluorine or C1-C10 fluoroalkyl, R2 is C1-C10 alkylene or fluoroalkylene, and R3 is an acid labile group are novel. They can be polymerized into polymers which are used to formulate resist compositions, which are processed by the lithography involving ArF exposure, offering many advantages including improved resolution and transparency, minimal line edge roughness, improved etch resistance, and especially minimal surface roughness after etching.Type: GrantFiled: May 25, 2006Date of Patent: October 2, 2007Assignees: Shin-Etsu Chemical Co., Ltd., Central Glass Co., Ltd.Inventors: Yuji Harada, Jun Hatakeyama, Yoshio Kawai, Kazuhiko Maeda, Haruhiko Komoriya, Michitaka Ootani
-
Patent number: 7276624Abstract: Hexafluoroisobutylene and its higher homologs are easily reacted with SO3 to give fluorosulfates of the formula CH2?C(R)CF2OSO2F, wherein R is a linear, branched or cyclic fluoroalkyl group comprised of 1 to 10 carbon atoms and may contain ether oxygen. These compounds react under mild conditions with many nucleophiles to give CH2?C(R)CF2X, where X is derived from the nucleophile. This reaction provides a route to many substituted hexafluoroisobutylenes, which copolymerize easily with other fluoro- and hydrocarbon monomers such as vinylidene fluoride and ethylene.Type: GrantFiled: May 9, 2003Date of Patent: October 2, 2007Assignee: E. I. du Pont de Nemours and CompanyInventors: Victor Filippovich Cherstkov, Nina Ivanova Delyagina, Richard E. Fernandez, Viacheslav A. Petrov, Paul R. Resnick
-
Patent number: 7276625Abstract: In this invention, a process is provided by which a carboxylic acid/diol mixture suitable as starting material for a polyester production is obtained from a decolorized carboxylic acid solution without isolation of a substantially dry carboxylic acid solid. More specifically, in this invention, a process is provided by which a terephthalic acid/ethylene glycol mixture suitable as starting material for a polyester production is obtained from a decolorized terephthalic acid solution without isolation of a substantially dry terephthalic acid solid.Type: GrantFiled: October 15, 2002Date of Patent: October 2, 2007Assignee: Eastman Chemical CompanyInventor: Robert Lin
-
Patent number: 7276626Abstract: A process for the production of a carboxylic acid and/or the alcohol ester of a carboxylic acid by carbonylating an alcohol and/or a reactive derivative thereof with carbon monoxide employing as the carbonylation catalyst, cobalt, rhodium or iridium coordinated with a tridentate ligand.Type: GrantFiled: May 5, 2004Date of Patent: October 2, 2007Assignee: BP Chemicals LimitedInventors: Sander Gaemers, John Glenn Sunley
-
Patent number: 7276627Abstract: A method for producing sequenced reaction products comprising performing, in one pot, a first reaction at a lower temperature followed by a second reaction at a higher temperature in the presence of a catalyst system comprising a proazaphosphatrane in combination with a palladium compound is provided. In one embodiment, the first reaction is a double amination reaction and the second reaction is an arylation. Use of one pot and a single catalyst system for each set of sequential reactions is efficient and economical. Novel N,N-diarylaminostyrenes and N,N-diarylaminostilbenes are produced according to the methods described herein.Type: GrantFiled: April 5, 2005Date of Patent: October 2, 2007Assignee: Iowa State University Research Foundation, Inc.Inventors: Nandakumar Mecheril Valsan, John G. Verkade
-
Patent number: 7276628Abstract: The invention relates to an aqueous solution containing at least one species selected from the group consisting of a 1:1 molar complex of TeO2 with a moiety of formula (A) and ammonium salts thereof: HO—X—OH (A); where X is an optionally substituted divalent saturated hydrocarbon group containing 2-8 carbon atoms in the chain connecting the two OH groups; and its use for stimulating cells to produce cytokines and for treating mammalian diseases and conditions responsive to increased production of cytokines. The complex may be used also for treating mammalian cancer which is not responsive to increased production of cytokines.Type: GrantFiled: November 24, 2002Date of Patent: October 2, 2007Assignee: BioMAS Ltd.Inventors: Michael Albeck, Benjamin Sredni
-
Patent number: 7276629Abstract: Provided are hydrogenation processes of sertraline imine intermediates with catalysts in various reactors.Type: GrantFiled: April 14, 2004Date of Patent: October 2, 2007Assignee: Teva Pharmaceutical Industries Ltd.Inventors: Mordechay Herskowitz, Mark Kaliya
-
Patent number: 7276630Abstract: A process is provided for preparing optionally substituted arylated benzylamines from the corresponding optionally substituted aryl halides and optionally substituted benzylamines using a specific solvent mixture, a base and a catalyst comprising a palladium compound and a bisaryldialkylphosphine.Type: GrantFiled: September 22, 2006Date of Patent: October 2, 2007Assignee: Saltigo GmbHInventors: Michael Dockner, Ulrich Scholz, Torsten Neugebauer
-
Patent number: 7276631Abstract: The present disclosure relates to chemical compounds and their use in human therapy. A specific embodiment of the disclosure relates to compounds of Formula (I); or an isomer, a pharmaceutically acceptable salt or solvate thereof or a pharmaceutically acceptable formulation comprising said compounds are useful for the useful for the treatment or prevention of conditions mediated by tachykinins and/or selective inhibition of serotonin reuptake transporter protein. The compounds act as dual NK-1 antagonists and selective serotonin reuptake inhibitors.Type: GrantFiled: July 18, 2005Date of Patent: October 2, 2007Assignee: Bristol-Myers Squibb CompanyInventors: Yong-Jin Wu, Huan He
-
Patent number: 7276632Abstract: The invention relates to a method for producing 2,3-cis-substituted 2-aryl propenals by condensing a 2-aryl acetaldehyde I with a non-enolizable aldehyde compound II in the presence of a base. The inventive method is characterized in that the reaction is carried out in a solvent mixture comprising at least one water-miscible organic solvent and water at a volume ratio Vsolvent:Vwater ranging between 10:1 and 0.5:1.Type: GrantFiled: December 14, 2004Date of Patent: October 2, 2007Assignee: BASF AktiengesellschaftInventors: Rainer Noack, Lothar Rüb, Clemens Palm
-
Patent number: 7276633Abstract: The present invention relates to a process for the preparation of a compound of the general formula R-(A1-Z-)mB—CF2O-A2-(A3)n—R???(I) in which R is alkyl, in which one or more CH2 groups may be replaced, independently of one another, by O, CF2, CH?CH, CH?CF or CF?CF, with the proviso that peroxide structures O—O and formaldehyde acetals O—CH2—O are excluded, A1 is, independently of one another, 1,4-cyclohexylene, 2,5-1,3-dioxanylene, 1,3-cyclobutylene or A2 and A3 are 1,4-phenylene, in which, independently of one another, from one to four hydrogens may be replaced by fluorine or one or two CH groups may be replaced by N, Z is a single bond, —CH2—CH2—, —CF2—CF2—, —CH?CH—, —CF?CF—, —CH?CF— or —CF?CH—, B is 2,6-disubstituted naphthalene, 2,6-disubstituted 5,6,7,8-tetrahydronaphthalene or 2,6-disubstituted trans-decalin, R? is R, F, OCF3, OCF2H, CF3, CI, SF5, CN or NCS, and m and n are, independently of one another, 0 or 1, comprising the following steps: a) conversion of a compound of the generaType: GrantFiled: October 30, 2003Date of Patent: October 2, 2007Assignee: Merck Patent GmbHInventors: Eike Poetsch, Werner Binder, Peer Kirsch, Andreas Taugerbeck
-
Patent number: 7276634Abstract: The present invention is an improvement upon the process for the production of 1,3-propanediol wherein an aqueous solution of 3-hydroxy propanal is formed, catalyst, if any, used in said formation is removed from the solution, sodium hydroxide is added to the solution to neutralize any acid therein such that the pH is at least about 5, the neutralized aqueous solution is subjected to hydrogenation to produce a crude 1,3-propanediol mixture which is distilled to produce 1,3-propanediol, water, and reactive heavy components. The improvement on this process comprises replacing the sodium hydroxide with a hydroxide selected from the group consisting of ammonium hydroxide, alkali metal hydroxides other than sodium hydroxide, and alkaline earth metal hydroxides to reduce the viscosity of the reactive heavy components.Type: GrantFiled: October 1, 2003Date of Patent: October 2, 2007Assignee: Shell Oil CompanyInventors: John Frederick Knifton, Talmadge Gail James, Paul Richard Weider, Joseph Broun Powell, Edward Lewis Nielsen, Glenn Charles Komplin
-
Patent number: 7276635Abstract: A process is provided for the production of a methyl halide by reacting carbon monoxide, hydrogen, and hydrogen halide over a catalyst to give methyl halide and carbon dioxide. The reaction is carried out under anhydrous conditions by using a ratio of carbon monoxide to hydrogen of 2-2.5:1. The catalyst contains a metal from the group copper and zinc. High conversion and yields are obtained in the process.Type: GrantFiled: September 10, 2004Date of Patent: October 2, 2007Inventor: John E. Stauffer
-
Patent number: 7276636Abstract: A styrene process is disclosed that uses a dehydrogenation reactor and a transalkylation reactor and in which a significant portion of the benzene, the inhibitors, or both, recovered from the dehydrogenation reactor passes to the transalkylation reactor. The process disclosed herein can also use an alkylation reactor and can increase the run length of the alkylation catalyst.Type: GrantFiled: August 17, 2005Date of Patent: October 2, 2007Assignee: UOP LLCInventor: John J. Jeanneret
-
Patent number: 7276637Abstract: A novel process for preparing cyclohexanone derivatives of formula (I) is described. The products are useful as gamma secretase inhibitors, or as intermediates in the synthesis of other gamma secretase inhibitors.Type: GrantFiled: July 30, 2003Date of Patent: October 2, 2007Assignees: Merck Sharp & Dohme Limited, Merck & Co., Inc.Inventors: Karel Marie Joseph Brands, Antony John Davies, Paul Joseph Oakley, Jeremy Peter Scott, Duncan Edward Shaw, Martin Richard Teall
-
Patent number: 7276638Abstract: The invention relates to a process for producing alkylated aromatic hydrocarbons, preferably with an oxygen or sulfur containing alkylating agent, in the presence of a multi-component molecular sieve catalyst composition that includes a molecular sieve and an active metal oxide. The invention is also directed to methods of making and formulating the multi-component molecular sieve catalyst composition useful in producing alkylated aromatics.Type: GrantFiled: March 29, 2006Date of Patent: October 2, 2007Assignee: ExxonMobil Chemical Patents Inc.Inventors: Jihad M. Dakka, James C. Vartuli, John S. Buchanan, Jose G. Santiesteban, Doron Levin, Lorenzo C. DeCaul
-
Patent number: 7276639Abstract: A hydrocarbon conversion process such as an auto-thermal cracking process in which a hydrocarbon feed and a molecular oxygen-containing gas are contacted in a reaction zone in the presence of a catalyst to produce an outlet stream having an oxygen concentration which is at, near or above the flammable limit and in which process a loss of reaction is detected and used as a signal to activate means for mitigating the risk of explosion downstream of the reaction zone. The loss of reaction may be detected for example by a sudden increase in oxygen concentration in the outlet stream and/or a sudden drop in temperature of the outlet stream.Type: GrantFiled: October 4, 2001Date of Patent: October 2, 2007Assignee: Ineos Europe LimitedInventors: Philip Hall, Ian Allan Beattie Reid, David Charles Wilson
-
Patent number: 7276640Abstract: Methods of reducing smoke levels in smoke-affected areas, reducing the level of toxic compounds produced by fires, fire suppression, and increasing flame retardancy. In particular, methods according to the present invention comprise dispersing nanocrystalline particles in the areas affected by smoke for sorption of smoke particulates and toxic compounds produced from a fire. The nanocrystalline particles are also effective for use in methods of fire suppression and flame retardancy.Type: GrantFiled: October 18, 2005Date of Patent: October 2, 2007Assignee: NanoScale CorporationInventors: Ravichandra S. Mulukutla, Paul S. Malchesky, Ronaldo Maghirang, John S. Klabunde, Kenneth J. Klabunde, Olga Koper
-
Patent number: 7276641Abstract: An aqueous hot melted type adhesive base material containing 4-biphenylyl acetic acid (BPAA) is provided. The adhesive base material contains constant amounts of BPAA and has good drug releasability, so that bioavailability of the drug is enhanced. An analgesic and anti-inflammatory external plaster containing BPAA is also provided. The plaster is obtained by dissolving BPAA into an aqueous hot melted type adhesive base material comprising as essential components a styrene-isoprene-styrene block copolymer, an adhesive resin, an antioxidant, lanolin, and water.Type: GrantFiled: September 6, 2005Date of Patent: October 2, 2007Assignee: Teikoku Seiyaku Co., Ltd.Inventor: Toshikuni Kawaji
-
Patent number: 7276642Abstract: The present invention provides a pattern-unbonded material that has at least two distinct regions. One region has different bond pattern than another region. The different bond pattern provides different, specific functionality or characteristics to the material. In an embodiment, the one region provides an optimal mechanical fastener, hook engagement. The different characteristics include, but are not limited to, opacity, tensile strength or stiffness. The different characteristics are provided by a bond pattern specific to the particular region. The outer regions, in an embodiment, are stronger and appear more substantial by being more opaque than or color-shifted relative to an inner region. The outer regions, in an embodiment, are not directly backed or supported by the garment to which the material is attached. Accordingly, it is important for the outer regions to provide adequate strength, stiffness, color, and opacity absent the garment backing the outer regions.Type: GrantFiled: April 1, 2005Date of Patent: October 2, 2007Assignee: Kimberly-Clark Worldwide, Inc.Inventor: Tom R. Belau
-
Patent number: 7276643Abstract: The methodologies of the present invention demonstrate that a critical balance between pro- and anti-amyloidogenic molecules exists that regulates amyloid formation and cell death in Alzheimer's disease and Parkinson's disease. ?-Synuclein, the non-amyloidogenic homologue of ?-synuclein, is a negative modulator of ?-synuclein and A? aggregation, having neuroprotective properties against ?-synuclein and A? neurotoxicity and that ?-synuclein and therapeutic agents derived therefrom block amyloidogenesis and neurodegeneration in vivo. The method of the present invention establishes that ?-synuclein blocks A? aggregation either by direct inhibition of A? amyloidogenesis or indirectly via either ?-synuclein or its 35 a.a. NAC region, inferring neuroprotective characteristics within the effected cells.Type: GrantFiled: February 20, 2001Date of Patent: October 2, 2007Assignee: The Regents of the University of CaliforniaInventors: Eliezer Masliah, Edward Rockenstein, Hersey Mallory, legal representative, Margaret Mallory, deceased
-
Patent number: 7276644Abstract: The invention provides a transgenic mouse that is a model for myocardial function. Also provided are methods for using the transgenic mouse model to study heart muscle, cardiac disease and identify compounds effective in treating or preventing cardiac disease.Type: GrantFiled: December 30, 2003Date of Patent: October 2, 2007Assignee: Wisconsin Alumni Research FoundationInventors: Richard L. Moss, Bruno Sousa, legal representative, Jose A. A. De Santana Pereira, deceased
-
Patent number: 7276646Abstract: A synthetic polynucleotide encoding human lactoferrin, modified with respect to the natural gene so as to maximize its expression in vegetals, on the basis of the preferential use of the codons is described. Moreover, the vectors containing such sequence, that having regulation elements activated in a controlled way determine its tissue- and stage-specific expression are further described. The vegetal cells and the plants transformed with the afore mentioned vectors, as well as the production processes of functional foods, vegetal milks, and human lactoferrin, utilizing them are also described.Type: GrantFiled: July 19, 1999Date of Patent: October 2, 2007Assignee: Plantechno S.r.l.Inventor: Corrado Fogher
-
Patent number: 7276647Abstract: The invention relates to the genetic manipulation of organisms, particularly to the expression of P-glycoprotein genes in transformed plants and other organisms. Nucleotide sequences for the P-glycoprotein genes, particularly the Dw3 gene of sorghum, and methods for their use are provided. The sequences find use in modifying the growth of organisms, particularly plants. Additionally, the invention provides methods for producing stable dwarf crop plants, particularly stable dwarf sorghum plants.Type: GrantFiled: March 8, 2004Date of Patent: October 2, 2007Inventors: Gurmukh S. Johal, Dilbag S. Multani
-
Patent number: 7276648Abstract: A novel soybean cultivar, designated SN64195, is disclosed. The invention relates to the seeds of soybean cultivar SN64195, to the plants of soybean SN64195 and to methods for producing a soybean plant produced by crossing the cultivar SN64195 with itself or another soybean variety. The invention further relates to hybrid soybean seeds and plants produced by crossing the cultivar SN64195 with another soybean cultivar.Type: GrantFiled: September 10, 2002Date of Patent: October 2, 2007Assignee: Monsanto Technology LLCInventor: Roger L. Lussenden
-
Patent number: 7276649Abstract: According to the invention, there is provided a novel soybean variety, designated XB44D04. This invention thus relates to the seeds of soybean variety XB44D04, to the plants of soybean XB44D04, to plant parts of soybean variety XB44D04 and to methods for producing a soybean plant produced by crossing soybean variety XB44D04 with another soybean plant, using XB44D04 as either the male or the female parent. This invention also relates to methods for introgressing a transgenic or mutant trait into soybean variety XB44D04 and to the soybean plants and plant parts produced by those methods. This invention also relates to soybean varieties or breeding varieties and plant parts derived from soybean variety XB44D04, to methods for producing other soybean varieties or plant parts derived from soybean variety XB44D04 and to the soybean plants, varieties, and their parts derived from use of those methods.Type: GrantFiled: January 30, 2004Date of Patent: October 2, 2007Assignee: Pioneer Hi-Bred International, Inc.Inventor: Jeffrey Allan Thompson
-
Patent number: 7276650Abstract: An inbred maize line, designated PH70R, the plants and seeds of inbred maize line PH70R, methods for producing a maize plant, either inbred or hybrid, produced by crossing the inbred maize line PH70R with another maize plant, and hybrid maize seeds and plants produced by crossing the inbred line PH70R with another maize line or plant and to methods for producing a maize plant containing in its genetic material one or more transgenes and to the transgenic maize plants produced by that method. This invention also relates to inbred maize lines derived from inbred maize line PH70R, to methods for producing other inbred maize lines derived from inbred maize line PH70R and to the inbred maize lines derived by the use of those methods.Type: GrantFiled: February 24, 2004Date of Patent: October 2, 2007Assignee: Pioneer Hi-Bred International, Inc.Inventor: Mark David Hoffbeck
-
Patent number: 7276651Abstract: Broadly this invention provides an invention which is an inbred corn line GN05-61211. The methods for producing a corn plant by crossing the inbred line GN05-61211 are also encompassed by the invention. Additionally, the invention relates to the various parts of inbred GN05-61211 including culturable cells. This invention relates to hybrid corn seeds and plants produced by crossing the inbred line GN05-61211 with at least one other corn line.Type: GrantFiled: March 31, 2005Date of Patent: October 2, 2007Assignee: Golden Harvest Seeds, Inc.Inventor: Duane Wolf
-
Patent number: 7276652Abstract: A wheat variety designated XW03X, the plants and seeds of wheat variety XW03X, methods for producing a wheat plant produced by crossing the variety XW03X with another wheat plant, and hybrid wheat seeds and plants produced by crossing the variety XW03X with another wheat line or plant, and the creation of variants by mutagenesis or transformation of variety XW03X. This invention also relates to methods for producing other wheat varieties or breeding lines derived from wheat variety XW03X and to wheat varieties or breeding lines produced by those methods.Type: GrantFiled: November 30, 2005Date of Patent: October 2, 2007Assignee: Pioneer Hi-Bred International, Inc.Inventors: Gregory Charles Marshall, William Joseph Laskar, Robert Lewis Clarkson, Kyle Jay Lively
-
Patent number: 7276653Abstract: A carrier for holding a bass drum with two first connection mechanisms and one second connection mechanism. The second connection mechanism includes a connection member, which is arranged on the bass drum, and a slide member, which is arranged on the carrier. The distal end of the slide member is engaged with the connection member. Each first connection mechanism includes a hook receptacle, which is arranged on the bass drum and open in a downward direction, and a hook, which is arranged on the carrier and inserted in the receptacle.Type: GrantFiled: March 29, 2005Date of Patent: October 2, 2007Assignee: Hoshino Gakki Mfg. Co., Ltd.Inventor: Masahiro Shimada
-
Patent number: 7276654Abstract: A cymbals stand comprising upper and lower cymbals pairs on the stand, each pair having primary and secondary discs adapted to be moved relatively toward one another to clash; an actuator rod projecting upwardly, and movable upwardly and downwardly; and structure including a pin or pins for attaching at least one of the cymbals of at least one pair to the rod, to be moved by the rod relative to the other pair of cymbals.Type: GrantFiled: January 27, 2005Date of Patent: October 2, 2007Inventor: Joseph A. Parisi
-
Patent number: 7276655Abstract: The invention relates to a music synthesis system for synthesizing a corresponding digital music output according to commands from a music data file. The music data file comprises a plurality of music data units. Each music data unit records related information of the music. The music synthesis system comprises a wavetable, a memory, a music analyzer, a wavetable preprocessor, and a synthesizer. The wavetable pre-stores the digital sampling data. The memory has a predetermined memory capacity for storing data. The music analyzer receives the music data file, analyzes the music data units of the music data file, and generates a corresponding analysis result. The wavetable preprocessor selects the digital sampling data with relatively greater importance in the wavetable and stores the selected digital sampling data in the memory. The synthesizer selects the digital sampling data from the memory and synthesizes the digital music output.Type: GrantFiled: February 9, 2005Date of Patent: October 2, 2007Assignee: Mediatek IncorporatedInventors: Tzueng-yau Lin, Pei-chen Chang